...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Financials
8
Apr 07, 2020 04:10PM

Is Zenith up to date with RVX on what it owes?

 

Koo

4
Apr 09, 2020 09:59PM
Share
New Message
Please login to post a reply